TTK Healthcare vs Peers
- Market cap
- ₹1,426 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹726.70 – ₹1,362.56
TTK Healthcare ranks 1st by market capitalisation among 1 Drug Manufacturers - General companies tracked by ATS. Its largest peers are TTK Healthcare. Its P/E of 22.5 compares with a peer median of 22.5.
TTK Healthcare vs Drug Manufacturers - General peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| TTK Healthcare | 1,009.30 | -3.56% | 1,426 | 22.5 | 2.85 | 14.5% | +18.5% |
| TTK Healthcare | 1,009.30 | -3.56% | 1,426 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
TTK Healthcare peer comparison — frequently asked questions
Who are TTK Healthcare's competitors?
TTK Healthcare's listed peers in Drug Manufacturers - General include TTK Healthcare, ranked here by market capitalisation.
How does TTK Healthcare's P/E compare with its peers?
TTK Healthcare trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - General peers shown.
Which is the largest company among TTK Healthcare's peers?
By market capitalisation, the largest company in the group is TTK Healthcare at ₹1,426 crore, against ₹1,426 crore for TTK Healthcare.
Same Data For Peers
Trade TTK Healthcare With ATS
Track TTKHLTCARE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.